The Fond Investor on Cellebrite DI Ltd. (CLBT)

主要经营地 Israel

详细生意模式 Digital forensics software & hardware for 7K+ law enforcement agencies. Product suite: Inseyets (device extraction), Pathfinder (AI-powered analysis), Guardian (cloud evidence management), Guardian Investigate (spring 2026). ARR +21% 2025 (17% organic), guiding 18-19% 2026 (likely low-mid 20s). Federal division (20% ARR) reaccelerating post-FedRAMP cert unlocking Guardian cloud (9 petabyte deal pending).

护城河 🟢 Unique proprietary device-cracking AI moat (FBI San Bernardino, Trump shooter cases); 7K+ law enforcement customer lock-in; 55% Inseyets conversion targets additional 25%+; FedRAMP unlocks fed customer expansion; Corellium M&A ($16.1M ARR) adds mobile forensics depth

估值水平 EV/EBITDA 35.42x

EV/Market Cap $3.0B / $3.5B

网络观点 Digital forensics gold standard serving 7K+ law enforcement agencies; 21% ARR growth (17% organic) with conservative 18-19% 2026 guidance; FedRAMP cert & Guardian 100%+ growth provide dual catalysts

AI观点 Unique device-cracking moat (AI+hardware control) defensible but Apple/Google encryption hardening ongoing threat; 35x EBITDA valuation elevated; Guardian's 9 petabyte federal storage deal + Corellium $16M ARR + SCG drone forensics provide revenue diversification; FedRAMP unlock material but admin turnover headwind in 2025 suggests execution risk